Drug Shortage Report for ELOCTATE
Report ID | 151328 |
Drug Identification Number | 02430312 |
Brand name | ELOCTATE |
Common or Proper name | Eloctate |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | ANTIHEMOPHILIC FACTOR |
Strength(s) | 750UNIT |
Dosage form(s) | POWDER FOR SOLUTION KIT |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 750 |
ATC code | B02BD |
ATC description | VITAMIN K AND OTHER HEMOSTATICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2021-12-13 |
Estimated end date | 2022-03-29 |
Actual end date | 2022-03-28 |
Shortage status | Resolved |
Updated date | 2022-03-29 |
Company comments | Eloctate product remains available for all patients. If necessary, patients needing the 750IU vial size will have access to alternate vial sizes until resupply is available. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2022-03-29 | English | Compare |
v11 | 2022-03-28 | French | Compare |
v10 | 2022-03-28 | English | Compare |
v9 | 2022-03-24 | French | Compare |
v8 | 2022-03-24 | English | Compare |
v7 | 2022-03-16 | French | Compare |
v6 | 2022-03-16 | English | Compare |
v5 | 2021-12-17 | French | Compare |
v4 | 2021-12-17 | English | Compare |
v3 | 2021-12-16 | French | Compare |
v2 | 2021-12-16 | English | Compare |
v1 | 2021-12-16 | English | Compare |
Showing 1 to 12 of 12